Inotiv Inc (NOTV)

NASDAQ
53.44
+7.87(+17.27%)
After Hours
53.44
0.00(0.00%)
- Real-time Data
  • Volume:
    551,364
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    45.21 - 58.88

NOTV Overview

Prev. Close
45.57
Day's Range
45.21-58.88
Revenue
75.3M
Open
46.4
52 wk Range
7.15-60.66
EPS
-0.42
Volume
551,364
Market Cap
1.3B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
229,479
P/E Ratio
-
Beta
2.11
1-Year Change
646.89%
Shares Outstanding
24,234,837
Next Earnings Date
Feb 15, 2022
What is your sentiment on Inotiv Inc?
or
Market is currently closed. Voting is open during market hours.

  • Midday Gainers / Losers (04/25/2018)
    • BySeeking Alpha-

    Gainers: TZOO +25%. VICR +24%. IPI +19%. CCRC +16%. EYPT +16%. BASI +15%. GNPX +12%. UAVS +14%. USNA +12%. STNG +12%.Losers: ERN -35%. TRVG -22%. HF -17%. MGLN -16%. VTVT -15%. TER...

  • Midday Gainers / Losers
    • BySeeking Alpha-

    Gainers: MYCC +30%. HCOM +21%. CDNA +18%. LILAK +13%. KOOL +12%. HEBT +11%. ABEO +11%. NNBR +9%. BASI +9%. IPWR +8%.Losers: ITEK -48%. ANF -21%. ZN -17%. OCUL -14%. DRYS -12%. NBEV...

Inotiv Inc Company Profile

Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers’ data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It has an agreement with BioVaxys to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellBuyBuyStrong BuyStrong Buy
Technical IndicatorsStrong SellSellStrong BuyStrong BuyStrong Buy
SummaryStrong SellNeutralStrong BuyStrong BuyStrong Buy
  • can inotiv inc , stock cross 50 $ ???
    0
    • whats this stock?
      0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.